A Phase I Study to Assess Safety, Tolerability and Pharmacokinetics of OP0595
Status:
Completed
Trial end date:
2014-11-01
Target enrollment:
Participant gender:
Summary
The objectives of this study are to assess the safety, tolerability and pharmacokinetic
profile of OP0595 administered intravenously to healthy male, Caucasian, adult subjects at
single escalating doses.